↓ Skip to main content

Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate

Overview of attention for article published in Frontiers in oncology, April 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
20 X users
patent
1 patent

Citations

dimensions_citation
278 Dimensions

Readers on

mendeley
346 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate
Published in
Frontiers in oncology, April 2017
DOI 10.3389/fonc.2017.00078
Pubmed ID
Authors

Marco Corazzari, Mara Gagliardi, Gian Maria Fimia, Mauro Piacentini

Abstract

Perturbation of endoplasmic reticulum (ER) homeostasis results in a stress condition termed "ER stress" determining the activation of a finely regulated program defined as unfolded protein response (UPR) and whose primary aim is to restore this organelle's physiological activity. Several physiological and pathological stimuli deregulate normal ER activity causing UPR activation, such as hypoxia, glucose shortage, genome instability, and cytotoxic compounds administration. Some of these stimuli are frequently observed during uncontrolled proliferation of transformed cells, resulting in tumor core formation and stage progression. Therefore, it is not surprising that ER stress is usually induced during solid tumor development and stage progression, becoming an hallmark of such malignancies. Several UPR components are in fact deregulated in different tumor types, and accumulating data indicate their active involvement in tumor development/progression. However, although the UPR program is primarily a pro-survival process, sustained and/or prolonged stress may result in cell death induction. Therefore, understanding the mechanism(s) regulating the cell survival/death decision under ER stress condition may be crucial in order to specifically target tumor cells and possibly circumvent or overcome tumor resistance to therapies. In this review, we discuss the role played by the UPR program in tumor initiation, progression and resistance to therapy, highlighting the recent advances that have improved our understanding of the molecular mechanisms that regulate the survival/death switch.

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 346 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 346 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 73 21%
Student > Master 48 14%
Researcher 34 10%
Student > Bachelor 34 10%
Student > Doctoral Student 16 5%
Other 32 9%
Unknown 109 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 109 32%
Agricultural and Biological Sciences 38 11%
Medicine and Dentistry 28 8%
Pharmacology, Toxicology and Pharmaceutical Science 13 4%
Immunology and Microbiology 12 3%
Other 28 8%
Unknown 118 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#2,457,740
of 25,382,440 outputs
Outputs from Frontiers in oncology
#575
of 22,428 outputs
Outputs of similar age
#44,452
of 323,575 outputs
Outputs of similar age from Frontiers in oncology
#11
of 87 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,428 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,575 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.